Cargando...

Forging a link between oncogenic signaling and immunosuppression in melanoma

Immunosuppressive tumor microenvironments limit the efficacy of T cell-based immunotherapy. We have recently demonstrated that the inhibition of BRAF(V600E) with vemurafenib relieves interleukin-1 (IL-1)-induced T-cell suppression as mediated by melanoma tumor associated fibroblasts (TAFs). These re...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Khalili, Jahan S., Hwu, Patrick, Lizée, Gregory
Formato: Artigo
Lenguaje:Inglês
Publicado: Landes Bioscience 2013
Materias:
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC3601157/
https://ncbi.nlm.nih.gov/pubmed/23525189
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4161/onci.22745
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!